Recital 9, Regulation (EU) 2024/2806

In forcesince 31 Oct 2024

The Authority identified concerns. In particular, it concluded that metribuzin meets the criteria to be identified as an endocrine disruptor for the thyroid (T)-modality for humans and that it has not been demonstrated that the exposure of humans to that active substance in a plant protection product, under realistic proposed conditions of use, is negligible. Furthermore, the Authority concluded that the bystander and resident exposure estimates exceed the established limit value for all representative uses evaluated, and that the available studies were not sufficient to exclude a high risk to bees.